Brief: Haemonetics Corp - QTRLY Revenue $265 Million, Up 18%

Haemonetics

10/05/2022 12:16

May 10 (Reuters) - Haemonetics Corp  HAE.N :
    * QTRLY REVENUE $265 MILLION, UP 18%
    * QTRLY EARNINGS PER DILUTED SHARE $0.19
    * QTRLY ADJUSTED EARNINGS PER DILUTED SHARE $0.65
    * ISSUED ITS FISCAL 2023 GAAP TOTAL REVENUE GROWTH GUIDANCE
OF 5 –
9%
    * SEES 2023 ADJUSTED EARNINGS PER DILUTED SHARE $2.50 -
$2.90
    * Q4 EARNINGS PER SHARE VIEW $0.60, REVENUE VIEW $256.5
MILLION --
REFINITIV IBES DATA
    * FY2023 EARNINGS PER SHARE VIEW $2.75, REVENUE VIEW $1.03
BILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn96gNnla 
Further company coverage:  HAE.N 

 ((Reuters.Briefs@thomsonreuters.com;))